Alpine Immune Sciences, Inc.
Clinical trials sponsored by Alpine Immune Sciences, Inc., explained in plain language.
Now part of
Vertex Pharmaceuticals Incorporated
VRTX
NASDAQ
A clinical-stage biotech developing immunotherapies for cancer and autoimmune diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.